PensionDanmark Pensionsforsikringsaktieselskab decreased its position in shares of Ventas, Inc. (NYSE:VTR – Free Report) by 7.1% during the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 125,675 shares of the real estate investment trust’s stock after selling 9,608 shares during the quarter. PensionDanmark Pensionsforsikringsaktieselskab’s holdings in Ventas were worth $11,160,000 at the end of the most recent quarter.
Several other hedge funds also recently bought and sold shares of the company. Capital World Investors purchased a new position in shares of Ventas in the fourth quarter valued at about $594,116,000. Norges Bank purchased a new stake in shares of Ventas during the fourth quarter worth about $474,571,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of Ventas by 32,509.3% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,648,776 shares of the real estate investment trust’s stock worth $359,722,000 after purchasing an additional 4,634,520 shares in the last quarter. Cohen & Steers Inc. raised its stake in Ventas by 228.1% during the 4th quarter. Cohen & Steers Inc. now owns 4,606,355 shares of the real estate investment trust’s stock valued at $356,440,000 after purchasing an additional 3,202,323 shares during the period. Finally, Daiwa Securities Group Inc. raised its stake in Ventas by 188.7% during the 4th quarter. Daiwa Securities Group Inc. now owns 4,705,591 shares of the real estate investment trust’s stock valued at $364,119,000 after purchasing an additional 3,075,450 shares during the period. Institutional investors own 94.18% of the company’s stock.
Wall Street Analysts Forecast Growth
Several research analysts have weighed in on the company. Mizuho upped their price target on Ventas from $98.00 to $104.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 22nd. Raymond James Financial started coverage on shares of Ventas in a research report on Tuesday, June 16th. They set an “outperform” rating and a $94.00 price objective on the stock. JPMorgan Chase & Co. boosted their target price on shares of Ventas from $93.00 to $94.00 and gave the stock an “overweight” rating in a report on Monday, May 11th. Scotiabank dropped their target price on shares of Ventas from $95.00 to $88.00 and set a “sector perform” rating for the company in a research report on Thursday, June 18th. Finally, Royal Bank Of Canada raised their target price on shares of Ventas from $91.00 to $98.00 and gave the company an “outperform” rating in a research note on Monday, May 4th. Fifteen research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $97.56.
Insider Activity
In related news, Director Michael J. Embler purchased 2,500 shares of the company’s stock in a transaction that occurred on Wednesday, June 3rd. The stock was bought at an average price of $78.81 per share, for a total transaction of $197,025.00. Following the completion of the transaction, the director owned 19,202 shares in the company, valued at approximately $1,513,309.62. The trade was a 14.97% increase in their position. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Walter C. Rakowich sold 1,152 shares of the company’s stock in a transaction that occurred on Thursday, May 14th. The shares were sold at an average price of $90.20, for a total value of $103,910.40. Following the sale, the director owned 28,349 shares in the company, valued at approximately $2,557,079.80. This trade represents a 3.90% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.53% of the company’s stock.
Ventas Stock Performance
Shares of NYSE:VTR opened at $93.31 on Friday. The firm has a fifty day simple moving average of $89.49 and a two-hundred day simple moving average of $86.10. Ventas, Inc. has a 52 week low of $66.38 and a 52 week high of $101.60. The company has a quick ratio of 0.44, a current ratio of 0.44 and a debt-to-equity ratio of 0.86. The stock has a market capitalization of $47.87 billion, a P/E ratio of 172.81, a PEG ratio of 2.13 and a beta of 0.69.
Ventas Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Thursday, July 16th. Investors of record on Tuesday, June 30th were issued a $0.52 dividend. The ex-dividend date of this dividend was Tuesday, June 30th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.2%. Ventas’s dividend payout ratio (DPR) is presently 385.19%.
Ventas Company Profile
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
Featured Articles
- Five stocks we like better than Ventas
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR – Free Report).
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
